To provide better access to these products, PBMs should remove step therapy requirements from both drugs so patients and prescribers have easier access and increase use of SGLT2 therapies, which are generally less expensive but efficacious
Nicotinic acid, nicotinamide, and nicotinamide riboside: a molecular evaluation of NAD+ precursor vitamins in human nutrition
November 2025: Boehringer Ingelheim licensed a novel GLP-1 analogue candidate from a research partner to advance its pipeline for type 2 diabetes and obesity indications
This is one of the more translatable research directions to emerge from the GHRP literature
Its designed to help people with type 2 diabetes manage their blood sugar levels, and its also been making waves in the weight loss community for its effectiveness in curbing appetite
These findings support the EQ VAS as a promising instrument for cross-regional health comparisons, given its independence from value sets